메뉴 건너뛰기




Volumn 26, Issue 8, 2012, Pages 1128-1135

In vivo quantification of striatal dopamine D2 receptor occupancy by JNJ-37822681 using [11C]raclopride and positron emission tomography

Author keywords

11C raclopride; antipsychotic drug; Dopamine D2 receptor; JNJ 37822681; occupancy; PET

Indexed keywords

DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR BLOCKING AGENT; JNJ 37822681; RACLOPRIDE C 11; UNCLASSIFIED DRUG;

EID: 84864126110     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881111435251     Document Type: Article
Times cited : (17)

References (70)
  • 1
    • 34249085382 scopus 로고    scopus 로고
    • Striatal vs. extrastriatal dopamine D2 receptors in antipsychotic response-a double-blind PET study in schizophrenia
    • Agid O, Mamo D, Ginovart N, et al. Striatal vs. extrastriatal dopamine D2 receptors in antipsychotic response-a double-blind PET study in schizophrenia. Neuropsychopharmacology. 2007 ; 32: 1209-1215
    • (2007) Neuropsychopharmacology , vol.32 , pp. 1209-1215
    • Agid, O.1    Mamo, D.2    Ginovart, N.3
  • 2
    • 77957837936 scopus 로고    scopus 로고
    • Positron emission tomography measurement of dopamine D2 receptor occupancy in the pituitary and cerebral cortex: Relation to antipsychotic- induced hyperprolactinemia
    • Arakawa R, Okumura M, Ito H, et al. Positron emission tomography measurement of dopamine D2 receptor occupancy in the pituitary and cerebral cortex: relation to antipsychotic-induced hyperprolactinemia. J Clin Psychiatry. 2010 ; 71: 1131-1137
    • (2010) J Clin Psychiatry , vol.71 , pp. 1131-1137
    • Arakawa, R.1    Okumura, M.2    Ito, H.3
  • 3
    • 0024358369 scopus 로고
    • A rating scale for drug-induced akathisia
    • Barnes TR. A rating scale for drug-induced akathisia. Br J Psychiatry. 1989 ; 154: 672-676
    • (1989) Br J Psychiatry , vol.154 , pp. 672-676
    • Barnes, T.R.1
  • 4
    • 0027239726 scopus 로고
    • Dose-dependent occupancy of central dopamine D2 receptors by the novel neuroleptic CP-88,059-01: A study using positron emission tomography and 11 C-raclopride
    • Bench CJ, Lammertsma AA, Dolan RJ, et al. Dose-dependent occupancy of central dopamine D2 receptors by the novel neuroleptic CP-88,059-01: a study using positron emission tomography and 11 C-raclopride. Psychopharmacology (Berl). 1993 ; 112: 308-314
    • (1993) Psychopharmacology (Berl) , vol.112 , pp. 308-314
    • Bench, C.J.1    Lammertsma, A.A.2    Dolan, R.J.3
  • 5
    • 0033946969 scopus 로고    scopus 로고
    • Striatal and temporal cortical D2/D3 receptor occupancy by olanzapine and sertindole in vivo: A [123 I]epidepride single photon emission tomography (SPET) study
    • Bigliani V, Mulligan RS, Acton PD, et al. Striatal and temporal cortical D2/D3 receptor occupancy by olanzapine and sertindole in vivo: a [123 I]epidepride single photon emission tomography (SPET) study. Psychopharmacology (Berl). 2000 ; 150: 132-140
    • (2000) Psychopharmacology (Berl) , vol.150 , pp. 132-140
    • Bigliani, V.1    Mulligan, R.S.2    Acton, P.D.3
  • 7
    • 9844227354 scopus 로고    scopus 로고
    • Performance evaluation of a whole-body PET scanner using the NEMA protocol
    • Brix G, Zaers J, Adam LE, et al. Performance evaluation of a whole-body PET scanner using the NEMA protocol. J Nucl Med. 1997 ; 38: 1614-1623
    • (1997) J Nucl Med , vol.38 , pp. 1614-1623
    • Brix, G.1    Zaers, J.2    Adam, L.E.3
  • 8
    • 0023257168 scopus 로고
    • Synthesis of [methoxy-3H]- and [methoxy-11C]-labelled raclopride. Specific dopamine-D2 receptor ligands
    • Ehrin E, Gawell L, Hogberg T, de Paulis T, Strom P. Synthesis of [methoxy-3H]- and [methoxy-11C]-labelled raclopride. Specific dopamine-D2 receptor ligands. J Labelled Compd Radiopharm. 1987 ; 24: 931-940
    • (1987) J Labelled Compd Radiopharm , vol.24 , pp. 931-940
    • Ehrin, E.1    Gawell, L.2    Hogberg, T.3    De Paulis, T.4    Strom, P.5
  • 9
    • 0041349310 scopus 로고    scopus 로고
    • Analysis of D2 dopamine receptor occupancy with quantitative SPET using the high-affinity ligand [123I]epidepride: Resolving conflicting findings
    • Erlandsson K, Bressan RA, Mulligan RS, Ell PJ, Cunningham VJ, Pilowsky LS. Analysis of D2 dopamine receptor occupancy with quantitative SPET using the high-affinity ligand [123I]epidepride: resolving conflicting findings. Neuroimage. 2003 ; 19: 1205-1214
    • (2003) Neuroimage , vol.19 , pp. 1205-1214
    • Erlandsson, K.1    Bressan, R.A.2    Mulligan, R.S.3    Ell, P.J.4    Cunningham, V.J.5    Pilowsky, L.S.6
  • 10
    • 0026718710 scopus 로고
    • Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects
    • Farde L, Nordström AL, Wiesel FA, Pauli S, Halldin C, Sedvall G. Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects. Arch Gen Psychiatry. 1992 ; 49: 538-544
    • (1992) Arch Gen Psychiatry , vol.49 , pp. 538-544
    • Farde, L.1    Nordström, A.L.2    Wiesel, F.A.3    Pauli, S.4    Halldin, C.5    Sedvall, G.6
  • 11
    • 0030609108 scopus 로고    scopus 로고
    • A PET study of [11C]FLB 457 binding to extrastriatal D2-dopamine receptors in healthy subjects and antipsychotic drug-treated patients
    • Farde L, Suhara T, Nyberg S, et al. A PET study of [11C]FLB 457 binding to extrastriatal D2-dopamine receptors in healthy subjects and antipsychotic drug-treated patients. Psychopharmacology (Berl). 1997 ; 133: 396-404
    • (1997) Psychopharmacology (Berl) , vol.133 , pp. 396-404
    • Farde, L.1    Suhara, T.2    Nyberg, S.3
  • 12
    • 0023853769 scopus 로고
    • Central D2-dopamine receptor occupancy in schizophrenic patients treated with antipsychotic drugs
    • Farde L, Wiesel FA, Halldin C, Sedvall G. Central D2-dopamine receptor occupancy in schizophrenic patients treated with antipsychotic drugs. Arch Gen Psychiatry. 1988 ; 45: 71-76
    • (1988) Arch Gen Psychiatry , vol.45 , pp. 71-76
    • Farde, L.1    Wiesel, F.A.2    Halldin, C.3    Sedvall, G.4
  • 13
    • 0024430178 scopus 로고
    • D1- and D2-dopamine receptor occupancy during treatment with conventional and atypical neuroleptics
    • Farde L, Wiesel FA, Nordström AL, Sedvall G. D1- and D2-dopamine receptor occupancy during treatment with conventional and atypical neuroleptics. Psychopharmacology (Berl). 1989 ; 99: S28 - S31
    • (1989) Psychopharmacology (Berl) , vol.99
    • Farde, L.1    Wiesel, F.A.2    Nordström, A.L.3    Sedvall, G.4
  • 14
    • 0035055247 scopus 로고    scopus 로고
    • D2 and 5HT2A receptor occupancy of different doses of quetiapine in schizophrenia: A PET study
    • Gefvert O, Lundberg T, Wieselgren IM, et al. D2 and 5HT2A receptor occupancy of different doses of quetiapine in schizophrenia: a PET study. Eur Neuropsychopharmacol. 2001 ; 11: 105-110
    • (2001) Eur Neuropsychopharmacol , vol.11 , pp. 105-110
    • Gefvert, O.1    Lundberg, T.2    Wieselgren, I.M.3
  • 15
    • 33646137570 scopus 로고    scopus 로고
    • The striatal and extrastriatal D2/D3 receptor-binding profile of clozapine in patients with schizophrenia
    • Grunder G, Landvogt C, Vernaleken I, et al. The striatal and extrastriatal D2/D3 receptor-binding profile of clozapine in patients with schizophrenia. Neuropsychopharmacology. 2006 ; 31: 1027-1035
    • (2006) Neuropsychopharmacology , vol.31 , pp. 1027-1035
    • Grunder, G.1    Landvogt, C.2    Vernaleken, I.3
  • 16
    • 0031279782 scopus 로고    scopus 로고
    • Parametric imaging of ligand-receptor binding in PET using a simplified reference region model
    • Gunn RN, Lammertsma AA, Hume SP, Cunningham VJ. Parametric imaging of ligand-receptor binding in PET using a simplified reference region model. Neuroimage. 1997 ; 6: 279-287
    • (1997) Neuroimage , vol.6 , pp. 279-287
    • Gunn, R.N.1    Lammertsma, A.A.2    Hume, S.P.3    Cunningham, V.J.4
  • 17
    • 34547846251 scopus 로고    scopus 로고
    • Consensus nomenclature for in vivo imaging of reversibly binding radioligands
    • Innis RB, Cunningham VJ, Delforge J, et al. Consensus nomenclature for in vivo imaging of reversibly binding radioligands. J Cereb Blood Flow Metab. 2007 ; 27: 1533-1539
    • (2007) J Cereb Blood Flow Metab , vol.27 , pp. 1533-1539
    • Innis, R.B.1    Cunningham, V.J.2    Delforge, J.3
  • 18
    • 69749125065 scopus 로고    scopus 로고
    • No regional difference in dopamine D2 receptor occupancy by the second-generation antipsychotic drug risperidone in humans: A positron emission tomography study
    • Ito H, Arakawa R, Takahashi H, et al. No regional difference in dopamine D2 receptor occupancy by the second-generation antipsychotic drug risperidone in humans: a positron emission tomography study. Int J Neuropsychopharmacol. 2009 ; 12: 667-675
    • (2009) Int J Neuropsychopharmacol , vol.12 , pp. 667-675
    • Ito, H.1    Arakawa, R.2    Takahashi, H.3
  • 19
    • 0034109940 scopus 로고    scopus 로고
    • Antipsychotic agents differ in how fast they come off the dopamine D2 receptors. Implications for atypical antipsychotic action
    • Kapur S, Seeman P. Antipsychotic agents differ in how fast they come off the dopamine D2 receptors. Implications for atypical antipsychotic action. J Psychiatry Neurosci. 2000 ; 25: 161-166
    • (2000) J Psychiatry Neurosci , vol.25 , pp. 161-166
    • Kapur, S.1    Seeman, P.2
  • 20
    • 0035094264 scopus 로고    scopus 로고
    • Does fast dissociation from the dopamine D2 receptor explain the action of atypical antipsychotics?: A new hypothesis
    • Kapur S, Seeman P. Does fast dissociation from the dopamine D2 receptor explain the action of atypical antipsychotics?: A new hypothesis. Am J Psychiatry. 2001 ; 158: 360-369
    • (2001) Am J Psychiatry , vol.158 , pp. 360-369
    • Kapur, S.1    Seeman, P.2
  • 21
    • 0029026941 scopus 로고
    • The D2 dopamine receptor occupancy of risperidone and its relationship to extrapyramidal symptoms: A PET study
    • Kapur S, Remington G, Zipursky RB, Wilson AA, Houle S. The D2 dopamine receptor occupancy of risperidone and its relationship to extrapyramidal symptoms: a PET study. Life Sci. 1995 ; 57: L103 - L107
    • (1995) Life Sci , vol.57
    • Kapur, S.1    Remington, G.2    Zipursky, R.B.3    Wilson, A.A.4    Houle, S.5
  • 22
    • 0034025771 scopus 로고    scopus 로고
    • Relationship between dopamine D2 occupancy, clinical response, and side effects: A double-blind PET study of first-episode schizophrenia
    • Kapur S, Zipursky R, Jones C, Remington G, Houle S. Relationship between dopamine D2 occupancy, clinical response, and side effects: a double-blind PET study of first-episode schizophrenia. Am J Psychiatry. 2000a ; 157: 514-520
    • (2000) Am J Psychiatry , vol.157 , pp. 514-520
    • Kapur, S.1    Zipursky, R.2    Jones, C.3    Remington, G.4    Houle, S.5
  • 23
    • 0030300171 scopus 로고    scopus 로고
    • The D2 receptor occupancy profile of loxapine determined using PET
    • Kapur S, Zipursky RB, Jones C, et al. The D2 receptor occupancy profile of loxapine determined using PET. Neuropsychopharmacology. 1996 ; 15: 562-566
    • (1996) Neuropsychopharmacology , vol.15 , pp. 562-566
    • Kapur, S.1    Zipursky, R.B.2    Jones, C.3
  • 24
    • 0034091239 scopus 로고    scopus 로고
    • A positron emission tomography study of quetiapine in schizophrenia: A preliminary finding of an antipsychotic effect with only transiently high dopamine D2 receptor occupancy
    • Kapur S, Zipursky R, Jones C, Shammi CS, Remington G, Seeman P. A positron emission tomography study of quetiapine in schizophrenia: a preliminary finding of an antipsychotic effect with only transiently high dopamine D2 receptor occupancy. Arch Gen Psychiatry. 2000b ; 57: 553-559
    • (2000) Arch Gen Psychiatry , vol.57 , pp. 553-559
    • Kapur, S.1    Zipursky, R.2    Jones, C.3    Shammi, C.S.4    Remington, G.5    Seeman, P.6
  • 25
    • 0031595586 scopus 로고    scopus 로고
    • 5-HT2 and D2 receptor occupancy of olanzapine in schizophrenia: A PET investigation
    • Kapur S, Zipursky RB, Remington G, et al. 5-HT2 and D2 receptor occupancy of olanzapine in schizophrenia: a PET investigation. Am J Psychiatry. 1998 ; 155: 921-928
    • (1998) Am J Psychiatry , vol.155 , pp. 921-928
    • Kapur, S.1    Zipursky, R.B.2    Remington, G.3
  • 26
    • 0032982714 scopus 로고    scopus 로고
    • Clinical and theoretical implications of 5-HT2 and D2 receptor occupancy of clozapine, risperidone, and olanzapine in schizophrenia
    • Kapur S, Zipursky RB, Remington G. Clinical and theoretical implications of 5-HT2 and D2 receptor occupancy of clozapine, risperidone, and olanzapine in schizophrenia. Am J Psychiatry. 1999 ; 156: 286-293
    • (1999) Am J Psychiatry , vol.156 , pp. 286-293
    • Kapur, S.1    Zipursky, R.B.2    Remington, G.3
  • 27
    • 0030613524 scopus 로고    scopus 로고
    • The relationship between D2 receptor occupancy and plasma levels on low-dose oral haloperidol: A PET study
    • Kapur S, Zipursky R, Roy P, et al. The relationship between D2 receptor occupancy and plasma levels on low-dose oral haloperidol: a PET study. Psychopharmacology (Berl). 1997 ; 131: 148-152
    • (1997) Psychopharmacology (Berl) , vol.131 , pp. 148-152
    • Kapur, S.1    Zipursky, R.2    Roy, P.3
  • 28
    • 57349125689 scopus 로고    scopus 로고
    • Dose-occupancy study of striatal and extrastriatal dopamine D2 receptors by aripiprazole in schizophrenia with PET and [18F]fallypride
    • Kegeles LS, Slifstein M, Frankle WG, et al. Dose-occupancy study of striatal and extrastriatal dopamine D2 receptors by aripiprazole in schizophrenia with PET and [18F]fallypride. Neuropsychopharmacology. 2008 ; 33: 3111-3125
    • (2008) Neuropsychopharmacology , vol.33 , pp. 3111-3125
    • Kegeles, L.S.1    Slifstein, M.2    Frankle, W.G.3
  • 29
    • 0036272770 scopus 로고    scopus 로고
    • Regional selectivity in clozapine treatment?
    • Kessler RM, Meltzer HY. Regional selectivity in clozapine treatment?. Am J Psychiatry. 2002 ; 159: 1064-1065
    • (2002) Am J Psychiatry , vol.159 , pp. 1064-1065
    • Kessler, R.M.1    Meltzer, H.Y.2
  • 30
    • 27844538830 scopus 로고    scopus 로고
    • Occupancy of striatal and extrastriatal dopamine D2/D3 receptors by olanzapine and haloperidol
    • Kessler RM, Ansari MS, Riccardi P, et al. Occupancy of striatal and extrastriatal dopamine D2/D3 receptors by olanzapine and haloperidol. Neuropsychopharmacology. 2005 ; 30: 2283-2289
    • (2005) Neuropsychopharmacology , vol.30 , pp. 2283-2289
    • Kessler, R.M.1    Ansari, M.S.2    Riccardi, P.3
  • 31
    • 33747353835 scopus 로고    scopus 로고
    • Occupancy of striatal and extrastriatal dopamine D2 receptors by clozapine and quetiapine
    • Kessler RM, Ansari MS, Riccardi P, et al. Occupancy of striatal and extrastriatal dopamine D2 receptors by clozapine and quetiapine. Neuropsychopharmacology. 2006 ; 31: 1991-2001
    • (2006) Neuropsychopharmacology , vol.31 , pp. 1991-2001
    • Kessler, R.M.1    Ansari, M.S.2    Riccardi, P.3
  • 32
    • 50349086333 scopus 로고    scopus 로고
    • Neuropharmacology of second-generation antipsychotic drugs: A validity of the serotonin-dopamine hypothesis
    • Kuroki T, Nagao N, Nakahara T. Neuropharmacology of second-generation antipsychotic drugs: a validity of the serotonin-dopamine hypothesis. Prog Brain Res. 2008 ; 172: 199-212
    • (2008) Prog Brain Res , vol.172 , pp. 199-212
    • Kuroki, T.1    Nagao, N.2    Nakahara, T.3
  • 33
    • 0030468875 scopus 로고    scopus 로고
    • Simplified reference tissue model for PET receptor studies
    • Lammertsma AA, Hume SP. Simplified reference tissue model for PET receptor studies. Neuroimage. 1996 ; 4: 153-158
    • (1996) Neuroimage , vol.4 , pp. 153-158
    • Lammertsma, A.A.1    Hume, S.P.2
  • 34
    • 84862877299 scopus 로고    scopus 로고
    • Pharmacology of JNJ-37822681, a specific and fast-dissociating D2 antagonist for the treatment of schizophrenia
    • Langlois X, Megens A, Lavreysen H, et al. Pharmacology of JNJ-37822681, a specific and fast-dissociating D2 antagonist for the treatment of schizophrenia. Eur Neuropsychopharmacol. 2010 ; 20: S502
    • (2010) Eur Neuropsychopharmacol , vol.20 , pp. 502
    • Langlois, X.1    Megens, A.2    Lavreysen, H.3
  • 35
    • 34648830603 scopus 로고    scopus 로고
    • Differential effects of aripiprazole on D2, 5-HT2, and 5-HT1A receptor occupancy in patients with schizophrenia: A triple tracer PET study
    • Mamo D, Graff A, Mizrahi R, Shammi CM, Romeyer F, Kapur S. Differential effects of aripiprazole on D2, 5-HT2, and 5-HT1A receptor occupancy in patients with schizophrenia: a triple tracer PET study. Am J Psychiatry. 2007 ; 164: 1411-1417
    • (2007) Am J Psychiatry , vol.164 , pp. 1411-1417
    • Mamo, D.1    Graff, A.2    Mizrahi, R.3    Shammi, C.M.4    Romeyer, F.5    Kapur, S.6
  • 36
    • 2442457725 scopus 로고    scopus 로고
    • A PET study of dopamine D2 and serotonin 5-HT2 receptor occupancy in patients with schizophrenia treated with therapeutic doses of ziprasidone
    • Mamo D, Kapur S, Shammi CM, et al. A PET study of dopamine D2 and serotonin 5-HT2 receptor occupancy in patients with schizophrenia treated with therapeutic doses of ziprasidone. Am J Psychiatry. 2004 ; 161: 818-825
    • (2004) Am J Psychiatry , vol.161 , pp. 818-825
    • Mamo, D.1    Kapur, S.2    Shammi, C.M.3
  • 37
    • 0036357466 scopus 로고    scopus 로고
    • Action of atypical antipsychotics
    • Meltzer HY. Action of atypical antipsychotics. Am J Psychiatry. 2002 ; 159: 153-154
    • (2002) Am J Psychiatry , vol.159 , pp. 153-154
    • Meltzer, H.Y.1
  • 39
    • 12344326514 scopus 로고    scopus 로고
    • Treatments for schizophrenia: A critical review of pharmacology and mechanisms of action of antipsychotic drugs
    • Miyamoto S, Duncan GE, Marx CE, Lieberman JA. Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs. Mol Psychiatry. 2005 ; 10: 79-104
    • (2005) Mol Psychiatry , vol.10 , pp. 79-104
    • Miyamoto, S.1    Duncan, G.E.2    Marx, C.E.3    Lieberman, J.A.4
  • 40
    • 0026612906 scopus 로고
    • Time course of D2- dopamine receptor occupancy examined by PET after single oral doses of haloperidol
    • Nordström AL, Farde L, Halldin C. Time course of D2- dopamine receptor occupancy examined by PET after single oral doses of haloperidol. Psychopharmacology (Berl). 1992 ; 106: 433-438
    • (1992) Psychopharmacology (Berl) , vol.106 , pp. 433-438
    • Nordström, A.L.1    Farde, L.2    Halldin, C.3
  • 41
    • 0033014402 scopus 로고    scopus 로고
    • Suggested minimal effective dose of risperidone based on PET-measured D2 and 5-HT2A receptor occupancy in schizophrenic patients
    • Nyberg S, Eriksson B, Oxenstierna G, Halldin C, Farde L. Suggested minimal effective dose of risperidone based on PET-measured D2 and 5-HT2A receptor occupancy in schizophrenic patients. Am J Psychiatry. 1999 ; 156: 869-875
    • (1999) Am J Psychiatry , vol.156 , pp. 869-875
    • Nyberg, S.1    Eriksson, B.2    Oxenstierna, G.3    Halldin, C.4    Farde, L.5
  • 42
    • 0027341623 scopus 로고
    • 5-HT2 and D2 dopamine receptor occupancy in the living human brain. A PET study with risperidone
    • Nyberg S, Farde L, Eriksson L, Halldin C, Eriksson B. 5-HT2 and D2 dopamine receptor occupancy in the living human brain. A PET study with risperidone. Psychopharmacology (Berl). 1993 ; 110: 265-272
    • (1993) Psychopharmacology (Berl) , vol.110 , pp. 265-272
    • Nyberg, S.1    Farde, L.2    Eriksson, L.3    Halldin, C.4    Eriksson, B.5
  • 43
    • 0028982509 scopus 로고
    • D2 dopamine receptor occupancy during low-dose treatment with haloperidol decanoate
    • Nyberg S, Farde L, Halldin C, Dahl ML, Bertilsson L. D2 dopamine receptor occupancy during low-dose treatment with haloperidol decanoate. Am J Psychiatry. 1995a ; 152: 173-178
    • (1995) Am J Psychiatry , vol.152 , pp. 173-178
    • Nyberg, S.1    Farde, L.2    Halldin, C.3    Dahl, M.L.4    Bertilsson, L.5
  • 44
    • 0031014718 scopus 로고    scopus 로고
    • A PET study of 5-HT2 and D2 dopamine receptor occupancy induced by olanzapine in healthy subjects
    • Nyberg S, Farde L, Halldin C. A PET study of 5-HT2 and D2 dopamine receptor occupancy induced by olanzapine in healthy subjects. Neuropsychopharmacology. 1997 ; 16: 1-7
    • (1997) Neuropsychopharmacology , vol.16 , pp. 1-7
    • Nyberg, S.1    Farde, L.2    Halldin, C.3
  • 45
    • 0029583353 scopus 로고
    • Positron emission tomography studies on D2 dopamine receptor occupancy and plasma antipsychotic drug levels in man
    • Nyberg S, Nordström AL, Halldin C, Farde L. Positron emission tomography studies on D2 dopamine receptor occupancy and plasma antipsychotic drug levels in man. Int Clin Psychopharmacol. 1995b ; 10: 81-85
    • (1995) Int Clin Psychopharmacol , vol.10 , pp. 81-85
    • Nyberg, S.1    Nordström, A.L.2    Halldin, C.3    Farde, L.4
  • 46
    • 0034805368 scopus 로고    scopus 로고
    • Potentials and pitfalls using high-affinity radioligands in PET and SPET determinations on regional drug-induced D2 receptor occupancy-a simulation study based on experimental data
    • Olsson H, Farde L. Potentials and pitfalls using high-affinity radioligands in PET and SPET determinations on regional drug-induced D2 receptor occupancy-a simulation study based on experimental data. Neuroimage. 2001 ; 14: 936-945
    • (2001) Neuroimage , vol.14 , pp. 936-945
    • Olsson, H.1    Farde, L.2
  • 47
    • 34547110810 scopus 로고    scopus 로고
    • Antipsychotic efficacy: Relationship to optimal D2-receptor occupancy
    • Pani L, Pira L, Marchese G. Antipsychotic efficacy: relationship to optimal D2-receptor occupancy.. Eur Psychiatry. 2007 ; 22: 267-275
    • (2007) Eur Psychiatry , vol.22 , pp. 267-275
    • Pani, L.1    Pira, L.2    Marchese, G.3
  • 49
    • 0031973814 scopus 로고    scopus 로고
    • The relationship between risperidone plasma levels and dopamine D2 occupancy: A positron emission tomographic study
    • Remington G, Kapur S, Zipursky R. The relationship between risperidone plasma levels and dopamine D2 occupancy: a positron emission tomographic study. J Clin Psychopharmacol. 1998 ; 18: 82-83
    • (1998) J Clin Psychopharmacol , vol.18 , pp. 82-83
    • Remington, G.1    Kapur, S.2    Zipursky, R.3
  • 50
    • 0042029747 scopus 로고    scopus 로고
    • Atypical antipsychotic drug actions: Unitary or multiple mechanisms for 'atypicality'?
    • Roth BL, Sheffler D, Potkin SG. Atypical antipsychotic drug actions: unitary or multiple mechanisms for 'atypicality'?. Clin Neurosci Res. 2003 ; 3: 108-117
    • (2003) Clin Neurosci Res , vol.3 , pp. 108-117
    • Roth, B.L.1    Sheffler, D.2    Potkin, S.G.3
  • 51
    • 84864139978 scopus 로고    scopus 로고
    • Safety, tolerability and D2 occupancy of the fast-dissociating D2 antagonist JNJ-37822681 in healthy subjects
    • Schmidt M, De Boer P, Mannaert E, Iersel T, Van Nueten L. Safety, tolerability and D2 occupancy of the fast-dissociating D2 antagonist JNJ-37822681 in healthy subjects. Eur Neuropsychopharmacol. 2010a ; 20: S444
    • (2010) Eur Neuropsychopharmacol , vol.20 , pp. 444
    • Schmidt, M.1    De Boer, P.2    Mannaert, E.3    Iersel, T.4    Van Nueten, L.5
  • 52
    • 84862883746 scopus 로고    scopus 로고
    • Efficacy and safety of JNJ-37822681, a fast-dissociating D2 receptor antagonist, in the treatment of schizophrenia
    • Schmidt M, Janssens L, Kent J, et al. Efficacy and safety of JNJ-37822681, a fast-dissociating D2 receptor antagonist, in the treatment of schizophrenia. Eur Neuropsychopharmacol. 2010b ; 20: S484 - S485
    • (2010) Eur Neuropsychopharmacol , vol.20
    • Schmidt, M.1    Janssens, L.2    Kent, J.3
  • 53
    • 84864130375 scopus 로고    scopus 로고
    • D2 receptor occupancy with 11C-raclopride PET following single and multiple dose: Does steady state make a difference?
    • Schmidt M, Mannaert E, De Boer P, et al. D2 receptor occupancy with 11C-raclopride PET following single and multiple dose: does steady state make a difference?. Eur Neuropsychopharmacol. 2009 ; 19: S314
    • (2009) Eur Neuropsychopharmacol , vol.19 , pp. 314
    • Schmidt, M.1    Mannaert, E.2    De Boer, P.3
  • 54
    • 0036221550 scopus 로고    scopus 로고
    • Atypical antipsychotics: Mechanism of action
    • Seeman P. Atypical antipsychotics: Mechanism of action. Can J Psychiatry. 2002 ; 47: 27-38
    • (2002) Can J Psychiatry , vol.47 , pp. 27-38
    • Seeman, P.1
  • 55
    • 26444441486 scopus 로고    scopus 로고
    • An update of fast-off dopamine D2 atypical antipsychotics
    • Seeman P. An update of fast-off dopamine D2 atypical antipsychotics. Am J Psychiatry. 2005 ; 162: 1984-1985
    • (2005) Am J Psychiatry , vol.162 , pp. 1984-1985
    • Seeman, P.1
  • 56
    • 0031953450 scopus 로고    scopus 로고
    • Antipsychotic drugs which elicit little or no parkinsonism bind more loosely than dopamine to brain D2 receptors, yet occupy high levels of these receptors
    • Seeman P, Tallerico T. Antipsychotic drugs which elicit little or no parkinsonism bind more loosely than dopamine to brain D2 receptors, yet occupy high levels of these receptors. Mol Psychiatry. 1998 ; 3: 123-134
    • (1998) Mol Psychiatry , vol.3 , pp. 123-134
    • Seeman, P.1    Tallerico, T.2
  • 57
    • 0032973806 scopus 로고    scopus 로고
    • Rapid release of antipsychotic drugs from dopamine D2 receptors: An explanation for low receptor occupancy and early clinical relapse upon withdrawal of clozapine or quetiapine
    • Seeman P, Tallerico T. Rapid release of antipsychotic drugs from dopamine D2 receptors: an explanation for low receptor occupancy and early clinical relapse upon withdrawal of clozapine or quetiapine. Am J Psychiatry. 1999 ; 156: 876-884
    • (1999) Am J Psychiatry , vol.156 , pp. 876-884
    • Seeman, P.1    Tallerico, T.2
  • 58
  • 60
    • 68149148941 scopus 로고    scopus 로고
    • Cortical dopamine D2/D3 receptors are a common site of action for antipsychotic drugs-an original patient data meta-analysis of the SPECT and PET in vivo receptor imaging literature
    • Stone JM, Davis JM, Leucht S, Pilowsky LS. Cortical dopamine D2/D3 receptors are a common site of action for antipsychotic drugs-an original patient data meta-analysis of the SPECT and PET in vivo receptor imaging literature. Schizophr Bull. 2009 ; 35: 789-797
    • (2009) Schizophr Bull , vol.35 , pp. 789-797
    • Stone, J.M.1    Davis, J.M.2    Leucht, S.3    Pilowsky, L.S.4
  • 61
    • 12844261790 scopus 로고    scopus 로고
    • MR-based automatic delineation of volumes of interest in human brain PET images using probability maps
    • Svarer C, Madsen K, Hasselbalch SG, et al. MR-based automatic delineation of volumes of interest in human brain PET images using probability maps. Neuroimage. 2005 ; 24: 969-979
    • (2005) Neuroimage , vol.24 , pp. 969-979
    • Svarer, C.1    Madsen, K.2    Hasselbalch, S.G.3
  • 62
    • 0034974721 scopus 로고    scopus 로고
    • No support for regional selectivity in clozapine-treated patients: A PET study with [11C]raclopride and [11C]FLB 457
    • Talvik M, Nordstrom AL, Nyberg S, Olsson H, Halldin C, Farde L. No support for regional selectivity in clozapine-treated patients: A PET study with [11C]raclopride and [11C]FLB 457. Am J Psychiatry. 2001 ; 158: 926-930
    • (2001) Am J Psychiatry , vol.158 , pp. 926-930
    • Talvik, M.1    Nordstrom, A.L.2    Nyberg, S.3    Olsson, H.4    Halldin, C.5    Farde, L.6
  • 63
    • 0036855229 scopus 로고    scopus 로고
    • Quetiapine: An effective antipsychotic in first-episode schizophrenia despite only transiently high dopamine-2 receptor blockade
    • Tauscher-Wisniewski S, Kapur S, Tauscher J, et al. Quetiapine: an effective antipsychotic in first-episode schizophrenia despite only transiently high dopamine-2 receptor blockade. J Clin Psychiatry. 2002 ; 63: 992-997
    • (2002) J Clin Psychiatry , vol.63 , pp. 992-997
    • Tauscher-Wisniewski, S.1    Kapur, S.2    Tauscher, J.3
  • 64
    • 84864137154 scopus 로고    scopus 로고
    • Pharmacokinetics and central nervous system effects of the novel dopamine D2 receptor antagonist JNJ-37822681
    • Te Beek ET, Moerland M, De Boer P, et al. Pharmacokinetics and central nervous system effects of the novel dopamine D2 receptor antagonist JNJ-37822681. J Psychopharmacol. 2012 ; 26: 1119-1127
    • (2012) J Psychopharmacol , vol.26 , pp. 1119-1127
    • Te Beek, E.T.1    Moerland, M.2    De Boer, P.3
  • 65
    • 49649110740 scopus 로고    scopus 로고
    • Monthly administration of long-acting injectable risperidone and striatal dopamine D2 receptor occupancy for the management of schizophrenia
    • Uchida H, Mamo DC, Kapur S, et al. Monthly administration of long-acting injectable risperidone and striatal dopamine D2 receptor occupancy for the management of schizophrenia. J Clin Psychiatry. 2008 ; 69: 1281-1286
    • (2008) J Clin Psychiatry , vol.69 , pp. 1281-1286
    • Uchida, H.1    Mamo, D.C.2    Kapur, S.3
  • 66
    • 59049100213 scopus 로고    scopus 로고
    • Striatal and extrastriatal D2/D3-receptor-binding properties of ziprasidone: A positron emission tomography study with [18F]Fallypride and [11C]raclopride (D2/D3-receptor occupancy of ziprasidone)
    • Vernaleken I, Fellows C, Janouschek H, et al. Striatal and extrastriatal D2/D3-receptor-binding properties of ziprasidone: a positron emission tomography study with [18F]Fallypride and [11C]raclopride (D2/D3-receptor occupancy of ziprasidone). J Clin Psychopharmacol. 2008 ; 28: 608-617
    • (2008) J Clin Psychopharmacol , vol.28 , pp. 608-617
    • Vernaleken, I.1    Fellows, C.2    Janouschek, H.3
  • 67
    • 77957234962 scopus 로고    scopus 로고
    • Dopamine D2/3 receptor occupancy by quetiapine in striatal and extrastriatal areas
    • Vernaleken I, Janouschek H, Raptis M, et al. Dopamine D2/3 receptor occupancy by quetiapine in striatal and extrastriatal areas. Int J Neuropsychopharmacol. 2010 ; 13: 951-960
    • (2010) Int J Neuropsychopharmacol , vol.13 , pp. 951-960
    • Vernaleken, I.1    Janouschek, H.2    Raptis, M.3
  • 68
    • 0035675612 scopus 로고    scopus 로고
    • Extrastriatal and striatal D2 dopamine receptor blockade with haloperidol or new antipsychotic drugs in patients with schizophrenia
    • Xiberas X, Martinot JL, Mallet L, et al. Extrastriatal and striatal D2 dopamine receptor blockade with haloperidol or new antipsychotic drugs in patients with schizophrenia. Br J Psychiatry. 2001 ; 179: 503-508
    • (2001) Br J Psychiatry , vol.179 , pp. 503-508
    • Xiberas, X.1    Martinot, J.L.2    Mallet, L.3
  • 69
    • 0035983682 scopus 로고    scopus 로고
    • Dopamine D2 and D3 receptor occupancy in normal humans treated with the antipsychotic drug aripiprazole (OPC 14597): A study using positron emission tomography and [11C]raclopride
    • Yokoi F, Grunder G, Biziere K, et al. Dopamine D2 and D3 receptor occupancy in normal humans treated with the antipsychotic drug aripiprazole (OPC 14597): a study using positron emission tomography and [11C]raclopride. Neuropsychopharmacology. 2002 ; 27: 248-259
    • (2002) Neuropsychopharmacology , vol.27 , pp. 248-259
    • Yokoi, F.1    Grunder, G.2    Biziere, K.3
  • 70
    • 25444493183 scopus 로고    scopus 로고
    • Treatment response to olanzapine and haloperidol and its association with dopamine D receptor occupancy in first-episode psychosis
    • Zipursky RB, Christensen BK, Daskalakis Z, et al. Treatment response to olanzapine and haloperidol and its association with dopamine D receptor occupancy in first-episode psychosis. Can J Psychiatry. 2005 ; 50: 462-469
    • (2005) Can J Psychiatry , vol.50 , pp. 462-469
    • Zipursky, R.B.1    Christensen, B.K.2    Daskalakis, Z.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.